Roche's Trontinemab Raises the Bar for Alzheimer's Amyloid Clearance Alzheimer’s disease treatments may be on the cusp of a major breakthrough, thanks to Roche’s innovative antibody, trontinemab . This next-generation therapy has shown remarkable speed and effectivenes... Alzheimer’s amyloid plaques blood-brain barrier clinical trials drug development neurodegeneration trontinemab
GLP-1s: A Promising Frontier in Neurodegenerative Disease Treatment The recent surge in interest around GLP-1 receptor agonists has opened up exciting new avenues in medical science. Originally celebrated for their impact on diabetes and obesity, these medications are... Alzheimer’s brain health clinical trials GLP-1 neurodegeneration neuroprotection Parkinson’s